WALTHAM, Mass.--(BUSINESS WIRE)--OXiGENE, Inc. (NASDAQ: OXGN) (XSSE: OXGN), a leading developer of biopharmaceutical compounds to treat cancer and certain ophthalmologic diseases, announced today that Dr. Richard Chin, its President and Chief Executive Officer, will present at the 4th Annual International Conference on Antiangiogenesis at the Sheraton Boston Hotel in Boston, MA. Dr. Chin will present on Tuesday, October 17, 2006 at 1:30am ET.
